These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 33753063)

  • 1. Neuropeptide-S prevents 6-OHDA-induced gastric dysmotility in rats.
    Sinen O; Özkan A; Ağar A; Bülbül M
    Brain Res; 2021 Jul; 1762():147442. PubMed ID: 33753063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced expression of choline acetyltransferase in vagal motoneurons and gastric motor dysfunction in a 6-OHDA rat model of Parkinson's disease.
    Zheng LF; Wang ZY; Li XF; Song J; Hong F; Lian H; Wang Q; Feng XY; Tang YY; Zhang Y; Zhu JX
    Brain Res; 2011 Oct; 1420():59-67. PubMed ID: 21955729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered Expression of D1 and D2 Dopamine Receptors in Vagal Neurons Innervating the Gastric Muscularis Externa in a Parkinson's Disease Rat Model.
    Wang ZY; Lian H; Zhou L; Zhang YM; Cai QQ; Zheng LF; Zhu JX
    J Parkinsons Dis; 2016 May; 6(2):317-23. PubMed ID: 27164043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric dysregulation induced by microinjection of 6-OHDA in the substantia nigra pars compacta of rats is determined by alterations in the brain-gut axis.
    Toti L; Travagli RA
    Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G1013-23. PubMed ID: 25277799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Centrally Administered Neuropeptide-S Alleviates Gastrointestinal Dysmotility Induced by Neonatal Maternal Separation.
    Bülbül M; Sinen O
    Neurogastroenterol Motil; 2022 Jan; 34(1):e14269. PubMed ID: 34561917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in TH- and ChAT-immunoreactive neurons in the DMV and gastric dysmotility in an LPS-induced PD rat model.
    Zheng LF; Zhang Y; Chen CL; Song J; Fan RF; Cai QQ; Wang ZY; Zhu JX
    Auton Neurosci; 2013 Oct; 177(2):194-8. PubMed ID: 23701914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central neuropeptide-S treatment improves neurofunctions of 6-OHDA-induced Parkinsonian rats.
    Bülbül M; Sinen O; Özkan A; Aslan MA; Ağar A
    Exp Neurol; 2019 Jul; 317():78-86. PubMed ID: 30825442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of unilateral 6-OHDA lesion in medial forebrain bundle on the motor, cognitive dysfunctions and vulnerability of different striatal interneuron types in rats.
    Ma Y; Zhan M; OuYang L; Li Y; Chen S; Wu J; Chen J; Luo C; Lei W
    Behav Brain Res; 2014 Jun; 266():37-45. PubMed ID: 24613235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sex on chronic stress induced alterations in hindbrain catecholaminergic system and autonomic dysfunction resulting in gastrointestinal dysmotility.
    Zaman A; Özçelik H; Yücel E; Su Akkan S; Onsinejad T; Mert Yüksel S; Bülbül M
    Brain Res; 2024 Nov; 1842():149112. PubMed ID: 38969083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial organization of neurons in the dorsal motor nucleus of the vagus synapsing with intragastric cholinergic and nitric oxide/VIP neurons in the rat.
    Zhou SY; Lu YX; Yao H; Owyang C
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1201-9. PubMed ID: 18460697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of calcium-sensing receptor by its antagonist promotes gastrointestinal motility in a Parkinson's disease mouse model.
    Li YH; Jiang ZX; Xu Q; Jin TT; Huang JF; Luan X; Li C; Chen XY; Wong KH; Dong XL; Sun XR
    Biomed Pharmacother; 2024 May; 174():116518. PubMed ID: 38565057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the vagal pathway and gastric dopamine in the gastroparesis of rats after a 6-hydroxydopamine microinjection in the substantia nigra.
    Zheng LF; Song J; Fan RF; Chen CL; Ren QZ; Zhang XL; Feng XY; Zhang Y; Li LS; Zhu JX
    Acta Physiol (Oxf); 2014 Jun; 211(2):434-46. PubMed ID: 24410908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of dopamine receptors in cholinergic motoneurons of the hypoglossal nucleus in a 6-OHDA-induced Parkinson's disease rat model.
    Zhou L; Wang ZY; Lian H; Song HY; Zhang YM; Zhang XL; Fan RF; Zheng LF; Zhu JX
    Biochem Biophys Res Commun; 2014 Sep; 452(3):560-6. PubMed ID: 25172664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration.
    Pellegrini C; Antonioli L; Colucci R; Tirotta E; Gentile D; Ippolito C; Segnani C; Levandis G; Cerri S; Blandini F; Barocelli E; Ballabeni V; Bernardini N; Blandizzi C; Fornai M
    Neuropharmacology; 2017 Sep; 123():22-33. PubMed ID: 28526609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of chronic neuropeptide-S treatment on non-motor parameters in experimental model of Parkinson's disease.
    Sinen O; Bülbül M; Derin N; Ozkan A; Akcay G; Aslan MA; Agar A
    Int J Neurosci; 2021 Aug; 131(8):765-774. PubMed ID: 32441169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of hydrogen sulfide within the dorsal motor nucleus of the vagus in the control of gastric function in rats.
    Sun HZ; Yu KH; Ai HB
    Neurogastroenterol Motil; 2015 May; 27(5):618-26. PubMed ID: 25773343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in the expression of nNOS in the substantia nigra and subthalamic nucleus of 6-OHDA-lesioned rats: the effects of chronic treatment with l-DOPA and the nitric oxide donor, molsidomine.
    Czarnecka A; Lenda T; Domin H; Konieczny J; Smiałowska M; Lorenc-Koci E
    Brain Res; 2013 Dec; 1541():92-105. PubMed ID: 24129225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal dysfunction in a Parkinson's disease rat model and the changes of dopaminergic, nitric oxidergic, and cholinergic neurotransmitters in myenteric plexus.
    Zhu HC; Zhao J; Luo CY; Li QQ
    J Mol Neurosci; 2012 May; 47(1):15-25. PubMed ID: 21647710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease.
    Farrand AQ; Helke KL; Gregory RA; Gooz M; Hinson VK; Boger HA
    Brain Stimul; 2017; 10(6):1045-1054. PubMed ID: 28918943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central neuropeptide-S administration alleviates stress-induced impairment of gastric motor functions through orexin-A.
    Bülbül M; Sinen O; Bayramoğlu O
    Turk J Gastroenterol; 2020 Jan; 31(1):65-72. PubMed ID: 32009616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.